← FDA Drug Approvals (Drugs@FDA)

SULFASALAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1977-10-21

Drug application

FDA Application #
ANDA085828
Application type
Abbreviated New Drug Application (Generic)
Brand name
SULFASALAZINE
Generic name
SULFASALAZINE
Active ingredients
SULFASALAZINE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
WATSON LABS
Manufacturer
Teva Pharmaceuticals USA, Inc.
First approval
1977-10-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown